|
|
Volumn 19, Issue 10, 2005, Pages 1353-1355
|
|
Targeting the beta-catenin/APC pathway: A novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APC PROTEIN;
BETA CATENIN;
CASPASE;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
FLURBIPROFEN;
PROTEASOME;
ROFECOXIB;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL;
CELL STRAIN CACO 2;
COLON CARCINOGENESIS;
COLON CARCINOMA;
CONCENTRATION RESPONSE;
DNA DRUG COMPLEX;
DRUG MECHANISM;
DRUG TARGETING;
ENZYME ACTIVITY;
GEL MOBILITY SHIFT ASSAY;
GENETIC TRANSCRIPTION;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN LOCALIZATION;
SIGNAL TRANSDUCTION;
ADENOMATOUS POLYPOSIS COLI PROTEIN;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTICARCINOGENIC AGENTS;
BETA CATENIN;
CADHERINS;
CASPASES;
CELL LINE, TUMOR;
COLONIC NEOPLASMS;
CYCLOOXYGENASE 2;
DNA;
FLURBIPROFEN;
GLYCOGEN SYNTHASE KINASE 3;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LACTONES;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PYRAZOLES;
SIGNAL TRANSDUCTION;
SULFONAMIDES;
SULFONES;
TCF TRANSCRIPTION FACTORS;
|
|
EID: 23444442691
PISSN: 08926638
EISSN: None
Source Type: Journal
DOI: 10.1096/fj.04-3274fje Document Type: Article |
|
Times cited : (123)
|
|
References (0)
|
